|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/36 | |
| A61K 38/37 | |||
| A61P 7/00 | |||
| A61P 7/02 | |||
| A61P 7/04 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3412305 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18173179.5 |
| Europos patento paraiškos padavimo data | 2012-06-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-12-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161495884 P | 2011-06-10 | US | |
| 201161511901 P | 2011-07-26 | US | |
| 201161523790 P | 2011-08-15 | US |
| (72) |
SCHEIFLINGER, Friedrich, AT
TURECEK, Peter, Dr., AT
EWENSTEIN, Bruce, US
WONG, Wing Yen, US
SUITER, Tobias M., DE
|
| (73) |
Takeda Pharmaceutical Company Limited,
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |
| TREATMENT OF COAGULATION DISEASE BY ADMINISTRATION OF RECOMBINANT VWF |